Adolescent use of insulin and patient-controlled analgesia pump technology: a 10-year Food and Drug Administration retrospective study of adverse events.
This study examined more than 1600 medical device adverse event reports and categorized the frequency and cause of each event. The authors conclude that the adolescent population warrants special consideration when using device technology and a greater understanding of the safety problems that face this patient group.